Cases 51 - 60 of 177
BAUSCH HEALTH US, LLC et al v. TARO PHARMACEUTICALS U.S.A., INC. et al
as 3:2020cv02747
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, KAKEN PHARMACEUTICAL CO., LTD., BAUSCH HEALTH US, LLC and others
Defendant:
TARO PHARMACEUTICALS U.S.A., INC., TARO PHARMACEUTICAL INDUSTRIES LTD. and TARO PHARMACEUTICALS INC.
Cause Of Action: 35 U.S.C. § 271
Molina Healthcare, Inc. v. Actavis Elizabeth, LLC et al
as 2:2020cv00695
Defendant:
TARO PHARMACEUTICALS U.S.A., INC, Camber Pharmaceutical, Inc., MYLAN INC and others
Plaintiff:
Molina Healthcare, Inc.
Cause Of Action: 15 U.S.C. § 1
MSP Recovery Claims, Series LLC et al v. Actavis Elizabeth LLC et al
as 2:2020cv00231
Defendant:
PAR PHARMACEUTICAL COMPANIES, INC., MYLAN INC, HERITAGE PHARMACEUTICALS INC and others
Plaintiff:
Series PMPI, MSP Recovery Claims, Series LLC and MSPA CLAIMS 1, LLC
Cause Of Action: 15 U.S.C. § 1
Molina Healthcare, Inc. v. Actavis Elizabeth, LLC et al
as 3:2019cv08438
Defendant:
Par Pharmaceutical Companies, Inc., Camber Pharmaceutical, Inc., Emcure Pharmaceuticals, Ltd. and others
Plaintiff:
Molina Healthcare, Inc.
Cause Of Action: 15 U.S.C. § 1
MSP Recovery Claims, Series LLC et al v. Actavis Elizabeth LLC et al
as 3:2019cv01972
Defendant:
PAR Pharmaceutical Companies, Inc., Sandoz, Inc., Upshers-Smith Laboratories, LLC and others
Plaintiff:
MSP Recovery Claims, Series LLP, SERIES, PMPI, a designated series of MAO-MSO Recovery, MSPA Claims 1, LLC and others
Cause Of Action: 15 U.S.C. § 1
HEALTH CARE SERVICE CORP. v. ACTAVIS ELIZABETH, LLC et al
as 2:2019cv05819
Defendant:
EMCURE PHARMACEUTICALS, LTD., SANDOZ, INC., LUPIN PHARMACEUTICALS, INC. and others
Plaintiff:
HEALTH CARE SERVICE CORP.
Cause Of Action: 15 U.S.C. § 1
HUMANA INC. v. ACTAVIS ELIZABETH, LLC et al
as 2:2019cv04862
Defendant:
SANDOZ, INC., VERSAPHARM, INC., VALEANT PHARMACEUTICALS INTERNATIONAL and others
Plaintiff:
HUMANA INC.
Cause Of Action: 15 U.S.C. § 1
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Leo Pharma A/S et al v. Taro Pharmaceuticals U.S.A., Inc. et al
as 1:2019cv01051
Plaintiff:
Leo Pharma A/S, Foamix Pharmaceuticals Ltd. and Leo Pharma, Inc.
Defendant:
Taro Pharmaceuticals U.S.A., Inc. and Taro Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
LEO Pharma A/S et al v. Taro Pharmaceuticals U.S.A. et al
as 1:2019cv00221
Defendant:
Taro Pharmaceutical Industries, Ltd. and Taro Pharmaceuticals U.S.A.
Plaintiff:
LEO Pharma A/S, Foamix Pharmaceuticals Ltd. and LEO Pharma Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
